Recombinant Activated Factor VII as a General Haemostatic Agent:Evidence-Based Efficacy and Safety

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|2|2|155-161

ISSN： 1574-8863

Source： Current Drug Safety, Vol.2, Iss.2, 2007-05, pp. : 155-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Activated Recombinant Factor VII in Severe Bleeding – Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding

By  

Transfusion Medicine and Hemotherapy, Vol. 39, Iss. 2, 2012-03 ,pp. : 139-150

Karger

Access to resources Recommend Favorite

Recombinant activated factor VII in paediatric cardiac surgery

By Egan Jonathan   Lammi Ahti   Schell David   Gillis Jonathan   Nunn Graham  

Intensive Care Medicine, Vol. 30, Iss. 4, 2004-04 ,pp. : 682-685

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Safety of Recombinant Factor VII as Rescue for Severe Perioperative Bleeding in HeartMate II Recipients

By  

JOURNAL OF CARDIAC SURGERY (ELECTRONIC), Vol. 30, Iss. 6, 2015-06 ,pp. : 500-505

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Emerging Role of Recombinant-Activated Factor VII in Neurocritical Care

By Fewel Matthew E.   Park Paul  

Neurocritical Care, Vol. 1, Iss. 1, 2004-01 ,pp. : 19-30

Humana Press, Inc

Access to resources Recommend Favorite

Recombinant Factor VII (Activated) for Haemorrhagic Complications of Severe Sepsis Treated with Recombinant Protein C (Activated)

By  

Acta Haematologica, Vol. 116, Iss. 2, 2006-08 ,pp. : 126-130

Karger

Access to resources Recommend Favorite